par Marechal, Raphaël ;Demols, Anne ;Gay, France ;De Maertelaer, Viviane ;Arvanitakis, Marianna ;Hendlisz, Alain ;Van Laethem, Jean-Luc
Référence Pancreas, 36, 3, page (e16-e21)
Publication Publié, 2008-04
Référence Pancreas, 36, 3, page (e16-e21)
Publication Publié, 2008-04
Article révisé par les pairs
Titre: |
|
Auteur: | Marechal, Raphaël; Demols, Anne; Gay, France; De Maertelaer, Viviane; Arvanitakis, Marianna; Hendlisz, Alain; Van Laethem, Jean-Luc |
Informations sur la publication: | Pancreas, 36, 3, page (e16-e21) |
Statut de publication: | Publié, 2008-04 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Chemotherapy |
Elderly | |
Neoplasms | |
Pancreas | |
MeSH keywords: | Adenocarcinoma -- drug therapy -- mortality |
Adult | |
Age Factors | |
Aged | |
Aged, 80 and over | |
Antineoplastic Agents -- adverse effects -- therapeutic use | |
Deoxycytidine -- adverse effects -- analogs & derivatives -- therapeutic use | |
Drug Tolerance | |
Humans | |
Kaplan-Meier Estimate | |
Middle Aged | |
Pancreatic Neoplasms -- drug therapy -- mortality | |
Prognosis | |
Retrospective Studies | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase II |
Clinical Trial, Phase III | |
Journal Article | |
Multicenter Study | |
Langue: | Anglais |
Identificateurs: | urn:issn:0885-3177 |
info:doi/10.1097/MPA.0b013e31815f3920 | |
info:pii/00006676-200804000-00024 | |
info:scp/41149162302 | |
info:pmid/18362833 |